Convalescent plasma: Please donate blood or components and help.
From the Mayo Clinic who is running trials using convalescent plasma treatment. Please donate plasma if you can.
I think the LA Times created a sensational headline and jumped to a conclusion before the medical community. And we know what happens if we get ahead of the science!
Convalescent plasma (kon-vuh-LES-unt PLAZ-muh) therapy is an experimental treatment that some doctors are using for people with severe coronavirus disease 2019 (COVID-19).
No drug has been proved to be safe and effective for treating COVID-19. The U.S. Food and Drug Administration (FDA) hasn't approved any drugs specifically to treat people with COVID-19.
But, people who've recovered from COVID-19 have antibodies — proteins the body uses to fight off infections — to the disease in their blood. The blood from people who've recovered is called convalescent plasma. Plasma is the liquid portion of the blood.
Researchers hope that convalescent plasma can be given to people with severe COVID-19 to boost their ability to fight the virus. It also might help keep people who are moderately ill from becoming more ill and experiencing COVID-19 complications.
If you've had COVID-19 and recovered from it, consider donating blood through the American Red Cross or your local donation center. Either can provide information about the donation process.
Convalescent plasma therapy may be helpful for people with COVID-19 who aren't helped by other treatments. Some people with COVID-19 become very sick and don't respond to other treatments or drugs. These people often develop acute respiratory distress syndrome (ARDS) — a severe lung condition. They often require mechanical assistance, such as a ventilator, to breathe. These people also are in danger of developing organ failure.
It could also help other people who may have a higher risk of serious illness, such as people with chronic medical conditions, for example, heart disease or diabetes, or those who have weakened immune systems. Convalescent plasma could help these people from getting sicker if they get COVID-19.
Convalescent plasma might also be considered for family members or health care workers who have been exposed to someone with COVID-19 to potentially prevent them from getting COVID-19.
Doctors may choose to enroll the person with COVID-19 in an expanded access program and order convalescent plasma for him or her. This type of program provides access to investigational new drugs outside of clinical trials. This type of program is sometimes necessary when a disease is very severe or life-threatening, and there is no available treatment.
It's not yet known if convalescent plasma therapy will be an effective treatment for COVID-19.
The collective results from people receiving convalescent plasma therapy can provide information about the effectiveness of the therapy and whether it can become an approved therapy to treat COVID-19. In preliminary treatment, many people have benefited from convalescent plasma therapy. Researchers continue to evaluate the results from people who received the therapy.
By studying results of this therapy for COVID-19, doctors are getting closer to finding a treatment. In addition, learning more about the use of convalescent plasma therapy now will help health care workers be better prepared to provide optimal patient care.